Identification of urinary proteome signatures associated with triple-negative breast cancer

被引:0
|
作者
Lombardo, Michael N.
Roy, Roopali
Pories, Susan
Lotz, Meg
Aldakhlallah, Rama
Dillon, Simon T.
Libermann, Towia A.
Moses, Marsha A.
机构
关键词
D O I
10.1158/1538-7445.AM2023-5315
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
5315
引用
收藏
页数:2
相关论文
共 50 条
  • [31] Integrated Microarray Analytics for the Discovery of Gene Signatures for Triple-Negative Breast Cancer
    Zaka, Masood U. H.
    Peng, Yonghong
    Sutton, Chris W.
    2014 14TH UK WORKSHOP ON COMPUTATIONAL INTELLIGENCE (UKCI), 2014, : 294 - 299
  • [32] Secreted CLU is associated with the initiation of triple-negative breast cancer
    Zhang, Danfang
    Sun, Baocun
    Zhao, Xiulan
    Cui, Yanfen
    Xu, Shaoyan
    Dong, Xueyi
    Zhao, Jianmin
    Meng, Jie
    Jia, Xiaohua
    Chi, Jiadong
    CANCER BIOLOGY & THERAPY, 2012, 13 (05) : 321 - 329
  • [33] Triple-negative Breast Cancer is not Associated with Increased Nodal Metastases
    Gangi, A.
    Mirocha, J.
    Leong, T.
    Giuliano, A. E.
    ANNALS OF SURGICAL ONCOLOGY, 2014, 21 : S57 - S57
  • [34] Theranostics for Triple-Negative Breast Cancer
    Choi, Hyeryeon
    Kim, Kwangsoon
    DIAGNOSTICS, 2023, 13 (02)
  • [35] Advanced Triple-Negative Breast Cancer
    Patel, Grisma
    Prince, Alison
    Harries, Mark
    SEMINARS IN ONCOLOGY NURSING, 2024, 40 (01)
  • [36] What is triple-negative breast cancer?
    Irvin, William J., Jr.
    Carey, Lisa A.
    EUROPEAN JOURNAL OF CANCER, 2008, 44 (18) : 2799 - 2805
  • [37] Immunotherapy in Triple-Negative Breast Cancer
    Emens, Leisha A.
    CANCER JOURNAL, 2021, 27 (01): : 59 - 66
  • [38] Pembrolizumab in Triple-Negative Breast Cancer
    Altundag, Kadri
    NEW ENGLAND JOURNAL OF MEDICINE, 2022, 387 (15): : 1435 - 1436
  • [39] A Review of Triple-Negative Breast Cancer
    Ismail-Khan, Roohi
    Bui, Marilyn M.
    CANCER CONTROL, 2010, 17 (03) : 173 - 176
  • [40] Triple-negative breast cancer: an update
    Boolbol, Susan K.
    Cate, Sarah P.
    BREAST CANCER MANAGEMENT, 2014, 3 (02) : 127 - 129